Integrated BioPharma, Inc.

8-K Entered a material agreement; Terminated a material agreement Jul 2, 2026 8-K Results of operations (earnings release) May 8, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Other events Apr 15, 2026 8-K Entered a material agreement Feb 18, 2026 8-K Results of operations (earnings release) Feb 11, 2026 10-Q Quarter ended 2025-12-31 Feb 11, 2026 8-K Shareholder vote results Dec 1, 2025 8-K Results of operations (earnings release) Nov 10, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Sep 23, 2025 10-K Fiscal year ended 2025-06-30 Sep 23, 2025 8-K Results of operations (earnings release) May 14, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Changed accountants Apr 24, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Apr 21, 2025 8-K Results of operations (earnings release) Feb 13, 2025 10-Q Quarter ended 2024-12-31 Feb 13, 2025 8-K Shareholder vote results Dec 2, 2024 8-K Results of operations (earnings release) Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Sep 23, 2024 10-K Fiscal year ended 2024-06-30 Sep 20, 2024 8-K Results of operations (earnings release) May 10, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release) Feb 12, 2024 10-Q Quarter ended 2023-12-31 Feb 12, 2024 8-K Shareholder vote results Nov 27, 2023 8-K Results of operations (earnings release) Nov 9, 2023 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Sep 15, 2023 10-K Fiscal year ended 2023-06-30 Sep 15, 2023 8-K Results of operations (earnings release) May 11, 2023 10-Q Quarter ended 2023-03-31 May 11, 2023 8-K Other events Mar 21, 2023 8-K Entered a material agreement Mar 17, 2023 8-K Results of operations (earnings release) Feb 10, 2023 10-Q Quarter ended 2022-12-31 Feb 10, 2023 8-K Entered a material agreement Dec 6, 2022 8-K Shareholder vote results Nov 28, 2022